Purchase and Subsequent Delivery of Medicinal Tender - 138959421

Procurement Summary

Country: Poland

Summary: Purchase and Subsequent Delivery of Medicinal Products Used for Drug Programs and Rdtl (2)

Deadline: 11 May 2026

Posting Date: 03 Apr 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 138959421

Document Ref. No.: 231822-2026

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: PLN 143192

CPV Classification

33600000 - Pharmaceutical products

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Purchase and subsequent delivery of medicinal products used for drug programs and RDTL (2) Purchase and subsequent delivery of the medicinal product - DABRAFENIBUM Quality requirements for medicinal products are specified in the Act of September 6, 2001 - Law pharmaceuticals (consolidated text: Journal of Laws of 2016, item 2142, as amended), which in Art. 1(1)(1) states that it specifies, among others: the rules and procedure for authorizing medicinal products to be placed on the market, taking into account in particular the requirements regarding quality, effectiveness and safety of their use". In addition, the regulation of the Minister of Health of November 9, 2015 on the requirements of Good Manufacturing Practice (Journal of Laws of 2015, item 1979) specifies in detail the requirements for ensuring appropriate product quality medicinal. In the proceedings in question, the quality standard of medicinal products was defined by the Ordering Party by providing in the description of the subject of the order, which includes, among others: composition, form and route of administration and unit of measurement Purchase and successive delivery of the medicinal product - ABROCITINIBUM Purchase and subsequent delivery of the medicinal product - DAROLUTAMIDUM Purchase and subsequent delivery of the medicinal product - LORLATINIBUM Purchase and subsequent delivery of the medicinal product - MOMELOTINIBUM Purchase and successive delivery of the medicinal product - IXAZOMIBUM Purchase and subsequent delivery of the medicinal product - OSIMERTINIBUM Purchase and subsequent delivery of the medicinal product - VELAGLUCERASUM ALFA Purchase and subsequent delivery of a medicinal product...
Document Type: Contract Notice Reference Number: PIMMSWiA-2375/26/03/02/2026 Contract Type: supplies Estimated Value: 143192 - PLN Authority Type: body-pl Doc Title: Purchase and successive delivery of medicinal products used for drug programs and RDTL (2) Dispatch Date: 2026-04-02 Publish Date: 2026-04-03 Submission Date: 2026-05-11

Documents

 Tender Notice